What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis

PURPOSE: Combined therapy with transarterial chemoembolization (TACE) and apatinib is superior in therapeutic effect compared with TACE alone in patients with hepatocellular carcinoma (HCC). To determine the most suitable agent combined with apatinib for TACE treatment, we did a systematic review an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Fuhai, Xu, Chang, Xu, Xiangbo, Chen, Jiangxia, Geng, Hefeng, Yang, Chao, Zhang, Yingshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174538/
https://www.ncbi.nlm.nih.gov/pubmed/35692745
http://dx.doi.org/10.3389/fonc.2022.887332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174538/
https://www.ncbi.nlm.nih.gov/pubmed/35692745
http://dx.doi.org/10.3389/fonc.2022.887332

Ejemplares similares